Phagenesis Company
.jpg)
Phagenesis is engaged in developing a device to treat dysphagia, a condition that disables the safe swallowing of food.
Industry:
P4 Medicine
Headquarters:
Manchester, United Kingdom
Founded Date:
2007
Employees Number:
11-51
Funding Status:
M&A
Investors Number:
1
Estimated Revenue:
£730 000 - £7 300 000
Last Funding Date:
05-22-2013
Last Funding Type:
Series B
Register and Claim Ownership